SMTL ID : 6c0s.1

Factor XIA in complex with the inhibitor methyl (4-{6-[(1S)-2-[(3R)-1-acetylpiperidin-3-yl]-1-({(2E)-3-[5-chloro-2- (1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)ethyl]-3-chloropyridazin-4-yl}phenyl) carbamate

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.35 Å

Oligo State

monomer

Ligands

1 x EEJ: methyl (4-{6-[(1S)-2-[(3R)-1-acetylpiperidin-3-yl]-1-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)ethyl]-3-chloropyridazin-4-yl}phenyl)carbamate(Non-covalent)

EEJ.1: 30 residues within 4Å: Chain A: R.26, H.27, L.28, C.29, H.44, C.45, F.46, Y.47, Y.134, L.137, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, E.210, G.211, C.212, G.219, V.220, Y.221 Ligands: EDO.3, EDO.7 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.28, A:Y.134, A:I.141, A:K.185, A:T.206 Hydrogen bonds: A:H.27, A:G.186, A:D.187, A:S.188, A:S.188, A:G.211 Water bridges: A:H.44, A:G.209, A:G.209

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: K.160, R.161, R.177 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.161, A:R.177

12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 4 residues within 4Å: Chain A: K.185 Ligands: EEJ.1, EDO.7, EDO.8 2 PLIP interactions: 2 interactions with chain A Water bridges: A:K.185, A:K.185 EDO.4: 5 residues within 4Å: Chain A: N.36, T.102, V.103, G.104, Y.105 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.36, A:Y.105 EDO.5: 2 residues within 4Å: Chain A: R.9, L.62 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.9 Water bridges: A:N.63 EDO.6: 9 residues within 4Å: Chain A: V.8, G.10, E.11, W.12, P.13, G.60, I.61, S.108, L.145 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:V.8, A:G.10, A:W.12, A:G.60 Water bridges: A:P.13, A:S.108 EDO.7: 8 residues within 4Å: Chain A: L.137, K.185, G.209, E.210, G.211 Ligands: EEJ.1, EDO.3, EDO.8 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:G.209, A:G.211 Water bridges: A:K.185, A:K.185 EDO.8: 6 residues within 4Å: Chain A: E.89, W.208, G.209, E.210 Ligands: EDO.3, EDO.7 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.210 Water bridges: A:G.209, A:E.210 EDO.9: 2 residues within 4Å: Chain A: T.168, H.169 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.169, A:H.169 EDO.10: 2 residues within 4Å: Chain A: Q.25, I.67 2 PLIP interactions: 2 interactions with chain A Water bridges: A:Q.64, A:K.68 EDO.11: 9 residues within 4Å: Chain A: V.153, E.157, R.161, G.175, Y.176, R.177, E.216, R.217, P.218 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:E.157, A:E.157, A:R.161, A:Y.176, A:E.216 Water bridges: A:R.217 EDO.12: 6 residues within 4Å: Chain A: S.90, G.91, Y.92, T.168, K.170, M.171 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.90, A:Y.92, A:T.168 EDO.13: 4 residues within 4Å: Chain A: I.34, G.35, W.38, T.235 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.235 Water bridges: A:N.36 EDO.14: 4 residues within 4Å: Chain A: Y.85, M.87, A.88, E.89 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Y.85, A:A.88, A:E.89, A:E.89, A:E.89

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hu, Z. et al., Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitors. Bioorg. Med. Chem. Lett. (2018)

Release Date

2018-03-07

Peptides

Coagulation factor XI: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Coagulation factor XI

Related Entries With Identical Sequence